0001127602-17-031223.txt : 20171103 0001127602-17-031223.hdr.sgml : 20171103 20171103171357 ACCESSION NUMBER: 0001127602-17-031223 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171101 FILED AS OF DATE: 20171103 DATE AS OF CHANGE: 20171103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANDINE MICHAEL J CENTRAL INDEX KEY: 0001235600 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 171177433 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 021394136 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-11-01 0001520262 Alkermes plc. ALKS 0001235600 LANDINE MICHAEL J 852 WINTER ST. WALTHAM MA 02451 1 SVP, Corp Dev., Alkermes, Inc. Ordinary Shares 2017-11-01 4 M 0 15000 14.13 A 178693 D Ordinary Shares 2017-11-01 4 S 0 15000 48.7125 D 163693 D Employee Stock Option (Right to Buy) 14.13 2017-11-01 4 M 0 15000 0 D 2017-11-05 Ordinary Shares 15000 0 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/6/15. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/6/15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.49 to $49.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for Michael J. Landine 2017-11-03